Abouzid, Khaled

khaled.abouzid@pharma.asu.edu.eg

Department of Pharmaceutical Chemistry - Pharmacy
Interests: Anticancer drug discovery, design and synthesis, Antimicrobial,
Internal ID: rp12178
  • 2,885 Scopus Citations
  • 592 PubMed Citations

khaled__.jpg picture
 
 
Loading... 2 0 20 0 false
 
Full Name
Abouzid, Khaled
 
 
Personal Site
 
Scopus Author ID
 
WOS ID
 
Biography
Dr. Khaled Abouzid is a Professor of Pharmaceutical Chemistry, Faculty of Pharmacy, Ain Shams University, Prominent Scholar in Drug Discovery, Co-founding Director of Center of Drug Discovery and Development Research ASU He was nominated as the Acting Dean of the Faculty of Pharmacy, University of Sadat City from 8-2018 to 8-2022. He is currently a member of national pharmaceutical chemistry promotion committee
Dr. Abouzid’s research is directed towards drug discovery of bioactive small molecules with special emphasis on cannabinoids, targeted anticancer, anti-inflammatory, anti-viral anti-microbial agents and enzyme inhibitors. He has published over 150 research papers, two books and filed 14 patents in medicinal chemistry. He has Scopus H index of 28. He has supervised over 100 Master and PhD students in 7 universities. Dr Abouzid has research collaborations with German, British, Swedish, Canadian and US universities. He has also organized and presided over 34 international symposia and conferences.
Dr. Abouzid obtained his B.Sc. degree in Pharmaceutical Sciences from Cairo University in 1985, and his PhD. joint degree in Organic Chemistry from the Faculty of Pharmacy, Cairo University and School of Pharmacy University of Connecticut, USA.
Dr. Abouzid started his career in 1995 as a lecturer of Organic Chemistry at Cairo University, Faculty of Pharmacy. In 2001, he moved to the Department of Pharmaceutical Chemistry, Ain Shams University, and was promoted to Associate Professor in 2003. He did postdoctoral work with Professor Jochen Lehman of the Friedrich-Schiller-Universität Jena, Germany.

Publications

Refined By:
Fulltext:  No Fulltext

Results 41-60 of 107 (Search time: 0.0 seconds).

Issue DateTitleAuthor(s)
417-Jul-2017Eco-friendly synthesis of novel cyanopyridine derivatives and their anticancer and PIM-1 kinase inhibitory activitiesAbouzid, Khaled ; Al-Ansary, Ghada H; El- naggar, Abeer 
426-Jul-2017Synthesis, ADMET Properties, and Biological Evaluation of Benzothiazole Compounds Targeting Chemokine Receptor 2 (CXCR2)Mehanna, Wesam E; Lu, Tiangong; Debnath, Bikash; Lasheen, Deena S. ; Serya, Rabah A T; Abouzid, Khaled ; Neamati, Nouri
43Mar-2017Pyridazine Based Scaffolds as Privileged Structures in anti-Cancer TherapyJaballah, Maiy Youssef; Serya, Rabah Taha; Abouzid, Khaled 
44Nov-2016Design and Synthesis of 4-Anilinothieno[2,3-d]pyrimidine-Based Compounds as Dual EGFR/HER-2 InhibitorsAbd El Hadi, Soha R; Lasheen, Deena S. ; Hassan, Mahmoud A; Khaled A M Abouzid 
4521-Oct-2016Discovery of novel Tetrahydrobenzo[b]thiophene and pyrrole based scaffolds as potent and selective CB2 receptor ligands: The structural elements controlling binding affinity, selectivity and functionalityOsman, Noha A; Ligresti, Alessia; Klein, Christian D; Allarà, Marco; Rabbito, Alessandro; Di Marzo, Vincenzo; Abouzid, Khaled ; Abadi, Ashraf H
4615-Aug-2016Toward discovery of mutant EGFR inhibitors; Design, synthesis and in vitro biological evaluation of potent 4-arylamino-6-ureido and thioureido-quinazoline derivativesMowafy, Samar; Galanis, A; Doctor, Zainab M; Paranal, Raymond M; Lasheen, Deena S. ; Farag, Nahla A; Jänne, Pasi A; Abouzid, Khaled 
47Aug-2016Covalent EGFR Inhibitors: Binding Mechanisms, Synthetic Approaches, and Clinical ProfilesHossam, Monia; Lasheen, Deena S. ; Abouzid, Khaled 
48May-2016Quinoxaline-Based Scaffolds Targeting Tyrosine Kinases and Their Potential Anticancer ActivityEl Newahie, Aliya M S; Ismail, Nasser S M; Abou El Ella, Dalal ; Abouzid, Khaled 
492016Design, synthesis and biological evaluation of indazole–pyrimidine based derivatives as anticancer agents with anti-angiogenic and antiproliferative activitiesElsayed, Nevine M. Y.; Abou El Ella, Dalal ; Serya, Rabah A. T.; Tolba, Mai F.; Shalaby, Raed; Khaled A M Abouzid 
502016Furo[2,3-d]pyrimidine based derivatives as kinase inhibitors and anticancer agentsAziz, M.A. ; Serya, RAT; Lasheen, DS; Abouzid, Khaled 
51Dec-2015Discovery of Novel Peptidomimetics as Irreversible CHIKV NsP2 Protease Inhibitors Using Quantum Mechanical-Based Ligand DescriptorsEl-labbad, Eman M; Ismail, Mohammed A H; Abou Ei Ella, Dalal A; Ahmed, Marawan; Wang, Feng; Barakat, Khaled H; Abouzid, Khaled 
52Jun-2015Discovery of novel tricyclic pyrido[3',2':4,5]thieno[3,2-d]pyrimidin-4-amine derivatives as VEGFR-2 inhibitorsAbdel Aziz, Yasmine M; Said, Mohamed M; El Shihawy, Hosam A; Abouzid, Khaled 
532015Thieno[2,3-d]pyrimidine based derivatives as kinase inhibitors and anticancer agentsElrazaz, Eman ; Abou El Ella, Dalal ; Khaled A M Abouzid ; Rabah A.T. Serya; Nasser S.M. Ismail
542015Molecular modeling design, synthesis, and anti-hyprglycemic evaluation of certain 5-(aryl-alkoxy-benzylidine)-imidazolidine-2,4-dione derivatives as potential PPAR gamma agonistsIsmail, MAH; Abouzid, Khaled ; Abdou, NS; Lahham, A; Abou El Ella, Dalal 
552015Radioiodination and biological evaluation of Cladribine as potential agent for tumor imaging and therapyBayoumi, NA; Amin, AM; Ismail, NSM; Abouzid, Khaled ; El-Kolaly, MT
562015Design, synthesis, and antihypertensive evaluation of 2 '-tetrazolyl and 2 '-carboxy-biphenylylmethyl-pyrrolidine scaffolds substituted at their N-1, C-3, and C-4 positions as potential angiotensin II AT(1) receptor antagonistsIsmail, MAH; Aboul-Enein, MN; El-Azzouny, AA; Abouzid, Khaled ; Ismail, NSM
572015Targeting apoptotic machinery as approach for anticancer therapy: Smac mimetics as anticancer agentsElsayed, NMY; Abou El Ella, D.A. ; Serya, RAT; Abouzid, Khaled 
582015Design, synthesis and biological evaluation of Novel Curcumin Analogs with anticipated anticancer activityFawzy, IM; Youssef, KM; Ismail, NSM; Gullbo, J; Abouzid, Khaled 
592015Discovery of Potent Antiproliferative Agents Targeting EGFR Tyrosine Kinase Based on the Pyrido[3',2':4,5]thieno[3,2-d]pyrimidin-4-amine ScaffoldAziz, Yasmine Mohamed Abdel; Said, Mohamed Mokhtar; El Shihawy, Hosam Ahmed; Tolba, Mai ; Abouzid, Khaled 
60Oct-2014Design, synthesis and biological evaluation of type-II VEGFR-2 inhibitors based on quinoxaline scaffoldShahin, Mai I; Abou El Ella, Dalal ; Ismail, Nasser S M; Abouzid, Khaled